"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Good Samaritan is dedicated to delivering high quality, compassionate care to Kearney and nearby communities. Visit us at 10 E 31st St or call (308) 865-7100 for more information."

During the past decade, CHI Health Good Samaritan conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 86 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 62 clinical trials were completed. i.e. 98.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHI Health Good Samaritan" #1 sponsor was "National Cancer Institute (NCI)" with 121 trials, followed by "SWOG Cancer Research Network" with 40 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHI Health Good Samaritan" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "CHI Health Good Samaritan" are "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (8 trials), "Ovarian Seromucinous Carcinoma" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "CHI Health Good Samaritan" in a lesser frequency.

Most popular intervention types in "CHI Health Good Samaritan" are "Drug" (187 trials), "Other" (138 trials), "Biological" (104 trials), "Procedure" (60 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Quality-of-Life Assessment" (59 trials), "Questionnaire Administration" (37 trials), "Computed Tomography" (34 trials) and "Paclitaxel" (31 trials). Other intervention names were less common.

The vast majority of trials in "CHI Health Good Samaritan" are 181 trials for "All" genders, 43 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "CHI Health Good Samaritan". undefined are not yet recruiting, 63 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in CHI Health Good Samaritan, 3 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in CHI Health Good Samaritan, 5 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".